Take 90 seconds to hear from our CEO about how DermaSensor is helping clinicians like you catch lesions earlier, reduce unnecessary referrals, and give patients faster answers. Plus, what to prepare for your call.
Explore clinical evidence, reimbursement details, and how leading practices are using AI-powered spectroscopy to improve patient outcomes.
Miss Less Melanoma With Immediate, Non-Invasive Skin Cancer Risk Results
“I think this is a revolutionary new product that can help us aid in the management of safety and wellness for our patients. In that, we can highlight and see whether any areas, dark areas, could potentially be cancerous.”
“Integrating DermaSensor’s innovative technology into our practice, we now offer enhanced skin cancer assessment capabilities in our community, ensuring timely referrals for our patients.”
“If you have DermaSensor, in 15 or 30 seconds, you can advise your patient that this is something you are going to refer to a dermatologist, or keep an eye on it, and you can re-evaluate on their next visit.”
“I mean, a lot of my patients are very complex. It’s like an internal medicine practice.
You just had to, you just have to get it into your brain that it’s available.”
“For me, it was a no-brainer to choose the device…it’s crucial to recognize that skin cancers do not always present the same way in people of color.”
“The beauty of the device is how simple it is… it is simple, easy, and straightforward.”
“The feedback from patients has been excellent…giving them peace of mind about their skin cancer risk.”